Congenital hypothyroidism is a condition where a baby is born with a thyroid gland that doesn’t produce enough thyroid hormone, or in some cases, doesn’t develop at all. It affects roughly 1 in 2,000 to 1 in 4,000 newborns and is one of the most common preventable causes of intellectual disability. Nearly every baby born in the United States is screened for it within the first few days of life, and when treatment starts early, children go on to develop normally.
Why It Happens
Thyroid hormone is essential for brain development and growth, especially in the first two to three years of life. In congenital hypothyroidism, either the thyroid gland itself didn’t form properly or the gland is structurally normal but can’t manufacture hormone the way it should.
The first category, where the gland fails to develop normally, has historically been the more common cause. The thyroid might be missing entirely, be too small, or end up in the wrong location in the neck. In early newborn screening programs, this type accounted for the large majority of cases. But as screening has become more sensitive over the decades, the second category, where the gland is present but doesn’t work correctly, now represents 30 to 40 percent of diagnosed cases. These hormone-production defects are often genetic, caused by mutations in genes that control how the thyroid synthesizes, stores, or releases its hormone.
Several specific genes are linked to congenital hypothyroidism. Some affect how the thyroid gland forms during fetal development. Others affect the chemical machinery the gland uses to build thyroid hormone. In rare cases, gene mutations cause syndromic forms of the condition, meaning the thyroid problem comes alongside other issues. For example, mutations in one gene can cause a combined syndrome involving the brain, lungs, and thyroid. Mutations in another gene cause Pendred syndrome, which pairs thyroid dysfunction with hearing loss and inner ear malformations. Most cases, however, involve the thyroid alone.
How It’s Detected
Before newborn screening existed, congenital hypothyroidism often went undiagnosed for months. Physical signs in a newborn can be subtle and easy to miss. Babies may have prolonged jaundice, low muscle tone (sometimes described as a “floppy” baby), very large soft spots on the skull, constipation, or a hoarse cry. Many affected babies look perfectly healthy at birth because they received some thyroid hormone from their mother during pregnancy.
Today, a blood sample taken from the baby’s heel in the first 24 to 48 hours of life catches the vast majority of cases. The test measures either TSH (a hormone the brain releases to tell the thyroid to work harder) or free T4 (the actual thyroid hormone circulating in the blood), or both. When TSH is abnormally high, it signals the thyroid isn’t keeping up. The exact cutoff values vary by state and country, since each screening program calibrates its thresholds based on its own population data to balance catching real cases against triggering false alarms.
If the initial screen comes back abnormal, a confirmatory blood draw from the baby’s vein follows. When the confirmatory TSH is above 20 mIU/L, treatment typically begins right away, even if the T4 level looks normal. If the TSH is elevated but at or below 20 mIU/L, doctors may either start treatment or monitor levels closely every one to two weeks. A TSH that stays above 10 mIU/L over time is generally considered reason enough to begin treatment. For context, the normal upper limit of TSH in infants aged one to three months is around 4.1 to 4.8 mIU/L.
Treatment and What to Expect
The treatment is straightforward: a daily dose of synthetic thyroid hormone called levothyroxine, given by mouth. The starting dose is weight-based, and infants receive it once a day, usually as a crushed tablet mixed with a small amount of breast milk, formula, or water. Treatment should start as soon as possible after diagnosis, optimally by two weeks of age when the condition is identified on the first newborn screen. This timing matters most in severe cases, where the thyroid is absent or barely functioning.
Levothyroxine simply replaces what the baby’s own thyroid can’t produce. It’s the same molecule the body makes naturally. Because infants grow rapidly, the dose needs frequent adjustment. During the first year of life, blood tests to check TSH and free T4 levels happen frequently, often every few weeks initially, then spreading out as levels stabilize. Even after infancy, regular monitoring continues through early childhood to make sure the dose keeps pace with growth.
Does It Go Away?
That depends on the underlying cause. When the thyroid gland never formed or formed in the wrong location, the condition is permanent. The child will take levothyroxine for life. When the gland is present and the initial hormone levels were only mildly abnormal, there’s a chance the condition is transient, meaning it resolves on its own. Around age three, doctors may do a trial off medication to see whether the thyroid can function independently. If hormone levels stay normal without medication, treatment can stop. If levels drop, the child goes back on levothyroxine.
The three-year mark is chosen deliberately. By that age, the most critical window of thyroid-dependent brain development has passed, so briefly testing without medication carries minimal risk.
Long-Term Outlook
Before newborn screening programs existed, congenital hypothyroidism was a leading cause of preventable intellectual disability. Children who went months or years without treatment could experience permanent cognitive impairment, delayed motor skills, and growth problems. The introduction of universal screening in the 1970s and 1980s transformed outcomes dramatically.
Children who start treatment early and maintain adequate thyroid hormone levels throughout childhood generally achieve normal intelligence and develop on pace with their peers. The key variables are how quickly treatment begins and how consistently hormone levels are kept in the target range during the first few years. Severe cases where the thyroid is completely absent may still show subtle differences in processing speed or memory on detailed neurocognitive testing, but these differences are far smaller than what was seen before the era of early detection.
For parents, the practical reality is a daily medication, regular blood draws that become less frequent over time, and periodic visits with a pediatric endocrinologist. Children with congenital hypothyroidism attend regular schools, play sports, and live without significant restrictions. The condition requires lifelong attention in permanent cases, but it doesn’t define or limit what a child can do.